You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The European Commission recently awarded the company a two-year, €2.6 million Horizon 2020 grant to achieve its ambitions.
Semi-quantitative SARS-CoV-2 serology tests enable users to measure levels of neutralizing antibodies, but tests need to be more comparable across manufacturers, Siemens said.
The collaboration seeks to standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization.
The effort, called INNO4COV-19, was awarded €6.1 million last month to support the commercialization of new diagnostics.
The effort is one of 23 research projects selected as part of a new, €128 million EU package to combat COVID-19.
The IMI announced the call in February with an initial budget of €45 million but raised the total funding amount to €72 million.
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
Some believe that more could be done to help deliver diagnostics to the European market.
IVD manufacturers are hoping questions related to the UK's pending exit from the EU, as well as the new European IVD Regulation, will soon be resolved.